(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.



Fig. 5. RXRa serves as a carrier for TR3 translocation initiated by 9-cis retinoic acid. (A) Detection of TR3 translocation mediated by RXR{alpha} in living MGC80-3 cells. Living cells transfected with GFP-TR3 alone or together with RXR{alpha} were treated with 9-cis retinoic acid at different time points as indicated. The GFP-TR3 translocation from the nucleus to the cytoplasm was visualized under a fluorescent microscope. To detect the effect of LMB on TR3 translocation, transfected cells were pre-treated with LMB for 2 hours, followed by treatment of 9-cis retinoic acid for the indicated times. (B) Repression of endogenous RXR{alpha} and TR3 by antisense RXR{alpha}, antisense TR3 or TR3-siRNA. Cells were stably transfected with different expression vectors or transiently transfected with siRNA as described in Materials and Methods. Expression level of endogenous RXR{alpha} or TR3 was detected by western blotting. Empty vector and scrambled-siRNA were used as controls. {alpha}tubulin was used to quantify the amount of protein loaded in each lane. (C) Effects of antisense RXR{alpha}, antisense TR3 and TR3-siRNA on the translocation of RXR{alpha} and TR3. MGC80-3 cells were transfected with different expression vectors or siRNAs as described in B and then treated with 9-cis retinoic acid (1 µM) for 6 hours. Nuclear (N) and cytoplasmic (C) fractions were subjected to western blotting, probed with anti-TR3 or anti-RXR{alpha} antibody as indicated. {alpha}tubulin and lamin B1 were used as loading controls. Scrambled-siRNA was used as positive control.